Use of IMiD3, a Thalidomide Analog, as an Adjunct to Therapy for Experimental Tuberculous Meningitis

Lignende værker

• Use of IMiD3, a Thalidomide Analog, as an Adjunct to Therapy for Experimental Tuberculous Meningitis
  af: Tsenova, Liana, et al.
  Udgivet: (2002)
• Effective Immunomodulatory Treatment of Escherichia coli Experimental Sepsis with Thalidomide
  af: Giamarellos-Bourboulis, Evangelos J., et al.
  Udgivet: (2003)
• Thalidomide and Phosphodiesterase 4 Inhibitors as Host Directed Therapeutics for Tuberculous Meningitis: Insights From the Rabbit Model
  af: Ranjeet Kumar, et al.
  Udgivet: (2020-01-01)
• IMiD-Free Interval and IMiDs Sequence: Which Strategy Is Better Suited for Lenalidomide-Refractory Myeloma?
  af: Kazuhito Suzuki, et al.
  Udgivet: (2023-11-01)
• Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
  af: Yoo Jin Jung, et al.
  Udgivet: (2021-03-01)